Compare Mutual Funds
PGIM India Healthcare Fund
EquitySectoral-Pharma
Select a Mutual Fund
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹1000
-
Expense Ratio
2.65
-
NAV
₹11.75
-
Fund Started
19 Nov 2024
-
Fund Size
₹130.33 Cr
-
Exit Load
Exit load of 0.50%, if redeemed within 90 days.
-
1 Year
13.23%
-
3 Year
-
-
5 Year
-
-
Equity
94.89%
-
Cash
-0.13%
-
Top 10 Holdings
Name | Assets |
|---|---|
Divi's Laboratories Ltd. | 10.36% |
Sun Pharmaceutical Industries Ltd. | 10.25% |
Torrent Pharmaceuticals Ltd. | 8.49% |
Ajanta Pharma Ltd. | 4.96% |
Max Healthcare Institute Ltd. | 4.71% |
Dr. Lal Pathlabs Ltd. | 4.33% |
Mankind Pharma Ltd. | 4.04% |
Manipal Health Enterprises Ltd. | 3.68% |
Navin Fluorine International Ltd. | 3.24% |
Abbott India Ltd. | 3.12% |
-
Name
-
-
Start Date
-
-
Description
The scheme seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
-
Launch Date
19 Nov 2024
-
